US National OCS Liver Perfusion (OLP) Registry
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- TransMedics
- Study ID
- NCT05940857
- Status
- Recruiting
Conditions
- Liver Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- OCS Liver — DEVICEThe TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.
Study Details
This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.
Key Dates
- Start date
- Oct 14, 2021
- Status verified
- Aug 2024
- Primary completion
- Oct 31, 2031
- Completion
- Oct 31, 2031
Study Design
- Enrollment
- 100,000 participants (estimated)
Arms
- Arm: OCS Liver Transplant RecipientsThe US National OLP Registry will enroll all liver transplant recipients who are transplanted with an OCS-perfused donor liver in the Registry.
- Arm: Non-OCS Liver Transplant RecipientsPatients transplanted using other preservation modalities for clinical outcomes.
Primary Outcome Measure
Survival [ Time Frame: 5 years post-transplant ]
Central Contacts
- Kelly Jork978-494-3918
- Kausar Qidwai
Locations (22)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | Leigh McManus Robert Cannon, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic Hospital Arizona | Phoenix | Arizona | 85054 | Dakota Hohenwalter Amit K. Mathur, MD (PRINCIPAL_INVESTIGATOR) |
| University of California San Diego | La Jolla | California | 92037 | Denya Arellano Gabriel Schnickel, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| University of California San Francisco | San Francisco | California | 94143 | Joanne Kwan Garrett Roll, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic Hospital Florida | Jacksonville | Florida | 32224 | Jessica Toukmehji Shennen Mao, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University Hospital | Atlanta | Georgia | 30322 | Jeryl Huckaby Denise Jennifer Lo, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536 | Deepa Valvi Malay B Shah (PRINCIPAL_INVESTIGATOR) |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Madelyn Subocz David D. Lee, MD (PRINCIPAL_INVESTIGATOR) |
| Lahey Clinic Medical Center | Burlington | Massachusetts | 01805 | Kirsten Peterson Mohamed E. Akoad, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109 | Nicholas Demchuk Seth Waits, MD (PRINCIPAL_INVESTIGATOR) |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Matthew Callaghan Iman Francis Ahmed Nassar, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic Hospital Minnesota | Rochester | Minnesota | 55905 | Candy Peterman Julie K. Heimbach, MD (PRINCIPAL_INVESTIGATOR) |
| SSM Health Saint Louis University Hospital | St Louis | Missouri | 63103 | Craig Dedert Henry Randall, MD (PRINCIPAL_INVESTIGATOR) |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | Michelle Leahy Shaheed Merani, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| NY Presbyterian Hospital/Columbia Univ. Medical Center | New York | New York | 10032 | Rachel Nuccitelli Tomoaki Kato, MD (PRINCIPAL_INVESTIGATOR) |
| Carolinas Medical Center/Atrium Health | Charlotte | North Carolina | 28203 | Katheryn Peterson Dionisios Vrochides, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Duke Medical Center | Durham | North Carolina | 27710 | Jerry Turner Debra Sudan, MD (PRINCIPAL_INVESTIGATOR) |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | Willa Meyer Ashesh Shah, MD (PRINCIPAL_INVESTIGATOR) |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Morgan Marsh David Wojciechowski, DO (PRINCIPAL_INVESTIGATOR) |
| Houston Methodist | Houston | Texas | 77030 | Deborah Pokrass Mark Hobeika, MD (PRINCIPAL_INVESTIGATOR) |
| University Hospital, University of Texas Health Science Center | San Antonio | Texas | 78229 | Jillian Woodworth Tarunjeet S Klair, MD (PRINCIPAL_INVESTIGATOR) |
| University of Utah Medical Center | Salt Lake City | Utah | 84112 | Chinedu Nwaduru, MD Motaz Selim, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant CandidatesPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ PoolRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Expanding Liver Transplant Immunosuppression Minimization Via EverolimusPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Phoenix, Arizona
- EVR and EPO for Liver Transplant TolerancePHASE1 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California